Brief: Crescita Therapeutics Inc And Tetra Natural Health Collaborate To Enhance Transdermal Delivery Of Beta-Caryophyllene In Tetra's Dermatology Product Portfolio
04/02/2019 12:20
Feb 4 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA THERAPEUTICS INC AND TETRA NATURAL HEALTH
COLLABORATE
TO ENHANCE TRANSDERMAL DELIVERY OF BETA-CARYOPHYLLENE IN TETRA'S
DERMATOLOGY PRODUCT PORTFOLIO
Source text for Eikon: ID:nPn8hrrW2a
Further company coverage: CTX.TO
((Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium